Targeting G-quadruplexes to achieve antiviral activity

Area of Science:

• Virology
• Molecular Biology
• Medicinal Chemistry

Background:

• Emerging viruses and rapid mutation rates necessitate novel antiviral targets and therapies.
• Current antiviral drugs primarily target viral proteins, with limited focus on direct nucleic acid targeting.
• Non-canonical nucleic acid structures, such as G-quadruplexes (G4s), are increasingly recognized for their biological significance.

Purpose of the Study:

• To review the antiviral potential of G-quadruplex (G4)-binding molecules.
• To elucidate the mechanisms underlying the antiviral activity of G4-ligands.
• To explore G4s as a novel target for next-generation antiviral drug design.

Main Methods:

• Review of existing literature on viruses, G-quadruplexes, and G4-binding molecules.
• Analysis of reported antiviral activities associated with G4-ligand interactions.
• Commentary on the mechanistic basis of antiviral effects mediated by G4 targeting.

Main Results:

• G-quadruplexes (G4s) represent a class of non-canonical nucleic acid structures with significant biological roles.
• Molecules designed to selectively bind G4s have demonstrated antiviral properties.
• These G4-binding molecules offer a potential strategy for targeting viral infections.

Conclusions:

• G-quadruplexes (G4s) are emerging as promising targets for antiviral drug development.
• Understanding the mechanisms of G4-ligand action within infected cells is crucial.
• Further research into G4-targeting molecules could lead to the development of next-generation antiviral therapies.